Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology
Hills, R. A.; Tan, T. K.; Cohen, A. A.; Keefe, J. R.; Keeble, A. H.; Gnanapragasam, P. N.; Storm, K. N.; Hill, M. L.; Liu, S.; Gilbert-Jaramillo, J.; Afzal, M.; Napier, A.; James, W. S.; Bjorkman, P. J.; Townsend, A. R.; Howarth, M.
Show abstract
Defending against future pandemics may require vaccine platforms that protect across a range of related pathogens. The presentation of multiple receptor-binding domains (RBDs) from evolutionarily-related viruses on a nanoparticle scaffold elicits a strong antibody response to conserved regions. Here we produce quartets of tandemly-linked RBDs from SARS-like betacoronaviruses coupled to the mi3 nanocage through a SpyTag/SpyCatcher spontaneous reaction. These Quartet Nanocages induce a high level of neutralizing antibodies against several different coronaviruses, including against viruses not represented on the vaccine. In animals primed with SARS-CoV-2 Spike, boost immunizations with Quartet Nanocages increased the strength and breadth of an otherwise narrow immune response. Quartet Nanocages are a strategy with potential to confer heterotypic protection against emergent zoonotic coronavirus pathogens and facilitate proactive pandemic protection. One Sentence SummaryA vaccine candidate with polyprotein antigens displayed on nanocages induces neutralizing antibodies to multiple SARS-like coronaviruses.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals 97%
- Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants 96%
- Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 96%
Similar papers in this journal
- A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates 97%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 96%
- Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 96%
Similar papers in this journal
Similar papers in this journal
- From sequence to scaffold: computational design of protein nanoparticle vaccines from AlphaFold2-predicted building blocks 95%
- Cross-reactive sarbecovirus antibodies induced by mosaic RBD-nanoparticles 95%
- Phenotypic determinism and stochasticity in antibody repertoires of clonally expanded plasma cells 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.